ABARELIX (PPI-149), A NOVEL AND POTENT GNRH ANTAGONIST, INDUCES A RAPID AND PROFOUND REDUCTION IN TESTOSTERONE AND PSA IN ADVANCED PROSTATE-CANCER PATIENTS (PRCA)
M. Menon et al., ABARELIX (PPI-149), A NOVEL AND POTENT GNRH ANTAGONIST, INDUCES A RAPID AND PROFOUND REDUCTION IN TESTOSTERONE AND PSA IN ADVANCED PROSTATE-CANCER PATIENTS (PRCA), The Journal of urology, 159(5), 1998, pp. 1285-1285